Clinical trials
Homozygous Familial Hypercholesterolemia trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 3 |
| Regeneron Pharmaceuticals | 3 |
| Aegerion Pharmaceuticals, Inc. | 2 |
| Amryt Pharma | 2 |
| Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi) | 2 |
| Cerenis Therapeutics, SA | 1 |
| Novartis Pharmaceuticals | 1 |
| REGENXBIO Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Homozygous Familial Hypercholesterolemia | 15 |
| Hyperlipoproteinemia Type II | 7 |
| Hypercholesterolemia | 5 |
| Atherosclerosis | 3 |
| Cardiovascular Diseases | 3 |
| Lipid Metabolism Disorders | 2 |
| Dyslipidemias | 1 |
| Genetic Diseases, Inborn | 1 |
| Metabolic Diseases | 1 |
| Rare Diseases | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.